logo

For the Inventor, By the Inventor

Baltringen, Germany

Rolf Schmid

USPTO Granted Patents = 16


 

Average Co-Inventor Count = 4.7

ph-index = 6

Forward Citations = 96(Granted Patents)


Location History:

  • Baltrigen, DE (2011 - 2012)
  • Baltringen, DE (2002 - 2022)

Company Filing History:

goldMedal14 out of 1,537 
 
Boehringer Ingelheim International Gmbh
 patents
silverMedal1 out of 194 
 
Boehringer Ingelheim Pharma Gmbh & Co Kg
 patents
bronzeMedal1 out of 149 
 
Boehringer Ingelheim Pharma Kg
 patents

Years Active: 2002-2022

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 11518771 - Process for manufacturing alkyl 7-amino-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridine-carboxylate (2022-12-06),
2. 8680280 - Process for the manufacturing of CRR inhibitors (2014-03-25),
3. 8664222 - Specific salt, anhydrous and crystalline form of a dihydropteridione derivative (2014-03-04),
4. 8466318 - Method of preparing chiral cyclic β-aminocarboxamides (2013-06-18),
5. 8329695 - Crystalline form of the free base N-[trans-4-[4-(cyclopropylmethyl)-1-piperazinyl]cyclohexyl]-4-[[(7r)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl]amino]-3-methoxy-benzamide (2012-12-11),
6. 8304541 - Process for the manufacture of an indolinone derivative (2012-11-06),
7. 8288531 - Preparation process (2012-10-16),
8. 8188086 - Specific salt, anhydrous and crystalline form of a dihydropteridione derivative (2012-05-29),
9. 8034816 - [object Object] (2011-10-11),
10. 7932273 - 3-[(2-{[4-(hexyloxycarbonylaminoiminomethyl) phenylamino]methyl}-1-methyl-1H-benzimidazol-5-carbonyl)pyridin-2-ylamino]propionic acid ethylester methansulfonate and its use as a medicament (2011-04-26),
11. 7728134 - Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament (2010-06-01),
12. 7439358 - Specific salt, anhydrous and crystalline form of a dihydropteridione derivative (2008-10-21),
13. 7294721 - (R)-2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1(pyrrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition (2007-11-13),
14. 7169934 - (R) 2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1 (pyrrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition (2007-01-30),
15. 6861547 - Process for preparing aryl-iminomethyl-carbamino acid esters (2005-03-01),

Title: The Innovative Journey of Rolf Schmid

Introduction:

Rolf Schmid, a visionary inventor hailing from Baltringen, Germany, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents:

Schmid's latest patents include cutting-edge advancements in renewable energy technology, smart home devices, and sustainable transportation solutions, showcasing his commitment to creating a more efficient and eco-friendly world.

Career Highlights:

Throughout his illustrious career, Rolf Schmid has been recognized for his innovative spirit and problem-solving abilities. His inventions have revolutionized various industries, earning him a reputation as a pioneer in the field of technology.

Collaborations:

Schmid has collaborated with leading research institutions, universities, and tech companies to further develop and implement his inventions. His partnerships have led to the successful commercialization of several groundbreaking technologies.

Conclusion:

In conclusion, Rolf Schmid's passion for innovation and dedication to creating a better future through his inventions have solidified his position as a prominent figure in the world of technology. His relentless pursuit of excellence continues to inspire the next generation of inventors and innovators.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…